Anuncio
Anuncio

ABT

ABT logo

Abbott Laboratories

124.27
USD
Patrocinado
-1.03
-0.82%
02 ene, 10:31 UTC -5
Apertura

Informes de beneficios de ABT

Ratio de Sorpresa Positivo

ABT superó 29 de las últimas 39 estimaciones.

74%

Próximo informe

Fecha del próximo informe
20 ene 2026
Estimate for Q4 25 (Revenue/ EPS)
$11.92B
/
$1.51
Cambio implícito desde Q3 25 (Revenue/ EPS)
+4.87%
/
+16.15%
Cambio implícito desde Q4 24 (Revenue/ EPS)
+8.64%
/
+12.69%

Abbott Laboratories earnings per share and revenue

On 15 oct 2025, ABT reported earnings of 1.30 USD per share (EPS) for Q3 25, missing the estimate of 1.31 USD, resulting in a -1.06% surprise. Revenue reached 11.37 mil millones, compared to an expected 11.52 mil millones, with a -1.30% difference. The market reacted with a -2.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 27 analysts forecast an EPS of 1.51 USD, with revenue projected to reach 11.92 mil millones USD, implying an increase of 16.15% EPS, and increase of 4.87% in Revenue from the last quarter.
Preguntas frecuentes
For Q3 2025, Abbott Laboratories reported EPS of $1.30, missing estimates by -1.06%, and revenue of $11.37B, -1.3% below expectations.
The stock price moved down -2.87%, changed from $133.27 before the earnings release to $129.45 the day after.
The next earning report is scheduled for 20 ene 2026.
Based on 27 analysts, Abbott Laboratories is expected to report EPS of $1.51 and revenue of $11.92B for Q4 2025.
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio